Health

When things are looking bad or worse, try some perspective, advises Professor Laura Kubzansky from the Harvard T.H. Chan School of Public Health. Optimism makes things better.

The coronavirus has had an unexpected mental health impact, striking hardest where its physical impacts are lowest: among youths and young adults.

Despite worries that a new coronavirus variant may be able to evade vaccines just being distributed, a Harvard public health expert expressed confidence in the same technology that produced the vaccines in record time.

Harvard researchers launched new disease-modeling app for colleges and universities.

Harvard Chan School professor Eric Rimm looks at the updated U.S. dietary guidelines — what’s changed and what should change.

A new study finds that while regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, the benefits stop after age 70.

A large-scale international study uses metagenomics and blood analysis to uncover gut microbes associated with the risks for common illnesses such as diabetes, obesity, and heart disease.

Will the British variant’s transmissibility upset summer plans?

A biology-based mathematical model indicates why COVID-19 outcomes vary widely and how therapy can be tailored to match the needs of specific patient groups.

A study of diet has found that by adhering to specific guidelines, women can reduce more than one-third of incidence of gastroesophageal reflux disease symptoms.

In his new book, “Exercised: Why Something We Never Evolved to Do Is Healthy and Rewarding,” Daniel Lieberman ’86 explores exercising myths.

A new study has found that pregnant women with COVID-19 do not pass the virus to newborns, however, they may pass fewer-than-expected antibodies to newborns.

Paul Farmer awarded Berggruen Prize for Philosophy and Culture.

Fauci predicted herd immunity by next fall and “normality” by 2021’s end, as long as enough people get vaccinated to bring the pandemic to an end.

COVID-19 has not only sickened and killed millions around the globe, it has wreaked havoc on existing programs to fight health ills that affect millions more. Harvard T.H. Chan School of Public Health Dean Michelle Williams discusses with the Gazette an “action agenda” on global health for the incoming Biden administration.

Researchers find that obesity allows cancer cells to outcompete tumor-killing immune cells in a battle for fuel in mice.

Mortality rate after cancer surgery drops during 10-year period, but gap persists between Black and white patients.

Thomas Hübl, founder of the Academy of Inner Science, will offer a three-part workshop to Harvard faculty and staff to help them cope with the demands of the COVID-19 pandemic.

Evidence of a post-Thanksgiving surge should be emerging this week, a Harvard epidemiologist said, advising people who gathered together to get tested or assume they’re infected.

Harvard Medical School scientists reverse age-related vision loss, eye damage from glaucoma in mice.

Experts said the complex rollout of a coronavirus vaccine gives the U.S. a chance for a win after the virus gained the upper hand in its initial phase.

Barry Bloom from the Harvard T.H. Chan School of Public Health offers context about the news that two experimental vaccines appear to confer a high level of protection from the coronavirus.

Harvard psychiatric epidemiologist Karestan Koenen said acknowledging that this Thanksgiving will be hard is a first step toward a meaningful holiday.

Massachusetts General Hospital researchers examined six patients using a specialized magnetic resonance technique and found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain as patients who have suffered oxygen deprivation from other causes.

Delivering immune-stimulating nanoparticles to the lungs via red blood cells halts tumor growth in mice.

A new study describes how a 12-minute burst of cardio exercise impacted more than 80 percent of circulating metabolites, including pathways linked key bodily functions such as insulin resistance, oxidative stress, vascular reactivity, inflammation, and longevity.

For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients’ antibody development and response, suggests a new study.

As part of our series, artificial intelligence is examined through the medical lens. It may lift personalized treatment, fill gaps in access to care, and cut red tape, but risks abound.

William Hanage, an associate professor of epidemiology at the Harvard T.H. Chan School of Public Health, offers key advice as the holidays approach.

Harvard psychologists offer tips to survive political stress and strain